Our development programs rely on an international network with academic, clinic and industrial partners
Genoscience Pharma is committed to create strong relationships with world-renowned academic institutions and industry leaders sharing the same insight. Building a wide agreement network with academic laboratories, clinical sites and industrial leaders is central to Genoscience Pharma’s strategy. We are permanently looking for new collaborations in the field of oncology and liver diseases.
Since its creation, Genoscience Pharma has collaborated with many academic experts in the field of oncology for preclinical development studies, to better understand the underlying mechanisms of tumor growth, proliferation, cancer resistance and recurrence and the mechanism of action of our drug candidates. Successful collaborations were implemented with :
- Pr Thomas Decaens (Institut Albert Bonniot, Grenoble, France)
- Dr Julie Pannequin (Institut de Génomique Fonctionnelle, Montpellier, France)
- Pr Philippe Merle et Dr Claude Caron de Fromentel (CRCL, INSERM, Lyon France)
- Pr Jérôme Boursier (Centre Hospitalo-Universitaire, Angers, France)
The Company has arousen interest of a great number of investigational centers and clinical networks through Europe with Institut Jules Bordet (Brussels, Belgium), Grenoble CHU, Centre de Recherche en Cancérologie of Lyon, AP-HP, Saint-Joseph hospital of Marseille (France) and United States with Memorial Sloan-Kettering Cancer Center (New York, USA).